NHSN Reporting: Adverse Drug Events - Glycemic Control, published by HL7 International - Public Health Work Group. This is not an authorized publication; it is the continuous build for version 0.1.0). This version is based on the current content of https://github.com/HL7/fhir-nhsn-ade-ig/ and changes regularly. See the Directory of published versions
<MedicationAdministration xmlns="http://hl7.org/fhir">
<id value="medicationadministration-metformin-er"/>
<meta>
<versionId value="4"/>
<lastUpdated value="2021-03-30T01:37:24.451+00:00"/>
<source value="#t2FnpwH0BmpwZidT"/>
<profile
value="http://hl7.org/fhir/us/nhsn-ade/StructureDefinition/MedicationAdministration-Antidiabetics"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource "medicationadministration-metformin-er" Version "4" Updated "2021-03-30T01:37:24.451Z" </p><p style="margin-bottom: 0px">Information Source: #t2FnpwH0BmpwZidT!</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-MedicationAdministration-Antidiabetics.html">MedicationAdministration Antidiabetic Drugs</a></p></div><p><b>status</b>: completed</p><p><b>medication</b>: 24 HR metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/3.0.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#1043563)</span></p><p><b>subject</b>: <a href="Patient-patient-ade-1.html">Patient/patient-ade-1</a> ""</p><p><b>context</b>: <a href="Encounter-encounter-completed-inpatient-ade-1.html">Encounter/encounter-completed-inpatient-ade-1</a></p><p><b>effective</b>: 2021-01-04T04:30:00+01:00</p><h3>Dosages</h3><table class="grid"><tr><td>-</td><td><b>Route</b></td><td><b>Method</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td>Oral Route <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#26643006)</span></td><td>Swallow - dosing instruction imperative (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#421521009)</span></td><td>2 TAB<span style="background: LightGoldenRodYellow"> (Details: http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm code TAB = 'Tablet')</span></td></tr></table></div>
</text>
<status value="completed"/>
<medicationCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="1043563"/>
<display
value="24 HR metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet"/>
</coding>
<text
value="24 HR metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet"/>
</medicationCodeableConcept>
<subject>
<reference value="Patient/patient-ade-1"/>
</subject>
<context>
<reference value="Encounter/encounter-completed-inpatient-ade-1"/>
</context>
<effectiveDateTime value="2021-01-04T04:30:00+01:00"/>
<dosage>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="26643006"/>
<display value="Oral Route"/>
</coding>
</route>
<method>
<coding>
<system value="http://snomed.info/sct"/>
<code value="421521009"/>
<display
value="Swallow - dosing instruction imperative (qualifier value)"/>
</coding>
</method>
<dose>
<value value="2"/>
<unit value="TAB"/>
<system value="http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm"/>
<code value="TAB"/>
</dose>
</dosage>
</MedicationAdministration>